Corcept Therapeutics | CORT - Capital Ordinaire





Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Ardelyx USD 246.97M 2.62M 2026-03
Aurora Cannabis CAD 58.95M 2.24M 2026-03
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
J&J USD 2.41B 1.35M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Omeros USD 611K 17K 2023-12
Pacira USD 39.31M 1.81M 2026-03
Pfizer USD 5.7B 13M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
TG Therapeutics USD 155.31M 95K 2025-12